FORECAST Trial: Interview with Dr. Campbell Rogers

from Donut of Destiny · host SCCT: Society of Cardiovascular Computed Tomography

Alastair and Praveen are joined by Dr. Campbell Rogers, CMO and executive VP at HeartFlow, to discuss the recently-published FORECAST trial. What are the economic and clinical outcomes of selective FFRct use in stable chest pain? Tune in and enjoy!

Episode metadata supplied by the publisher feed · Published Aug 24, 2021

Embed this episode

Attribution link and audio player

Ready to play

FORECAST Trial: Interview with Dr. Campbell Rogers

0:00 25:55

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Donut of Destiny?

This episode is 25 minutes long.

When was this Donut of Destiny episode published?

This episode was published on August 24, 2021.

Can I download this Donut of Destiny episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!